SAM
ONC

Storebrand Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Storebrand Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Sell
3,738
-930
-20% -$274K ﹤0.01% 649
2026
Q1 		$1.39M Sell
4,668
-2,181
-32% -$706K ﹤0.01% 611
2025
Q4 		$2.08M Sell
6,849
-47
-0.7% -$15.4K 0.01% 577
2025
Q3 		$2.35M Hold
6,896
– – 0.01% 582
2025
Q2 		$1.67M Hold
6,896
– – ﹤0.01% 608
2025
Q1 		$1.88M Hold
6,896
– – 0.01% 601
2024
Q4 		$1.27M Sell
6,896
-6,272
-48% -$1.28M ﹤0.01% 651
2024
Q3 		$2.96M Hold
13,168
– – 0.01% 571
2024
Q2 		$1.88M Sell
13,168
-224
-2% -$34.5K 0.01% 615
2024
Q1 		$2.09M Hold
13,392
– – 0.01% 625
2023
Q4 		$2.42M Sell
13,392
-1,952
-13% -$353K 0.01% 615
2023
Q3 		$2.76M Hold
15,344
– – 0.01% 565
2023
Q2 		$2.74M Hold
15,344
– – 0.01% 578
2023
Q1 		$3.31M Sell
15,344
-281
-2% -$67.4K 0.02% 552
2022
Q4 		$3.44M Sell
15,625
-888
-5% -$163K 0.02% 526
2022
Q3 		$2.23M Sell
16,513
-7,687
-32% -$1.32M 0.01% 573
2022
Q2 		$3.92M Buy
24,200
+1,535
+7% +$240K 0.02% 514
2022
Q1 		$4.27M Buy
22,665
+955
+4% +$203K 0.02% 520
2021
Q4 		$5.88M Buy
21,710
+1,612
+8% +$544K 0.03% 482
2021
Q3 		$7.3M Sell
20,098
-195
-1% -$63.8K 0.04% 430
2021
Q2 		$6.96M Buy
20,293
+3,701
+22% +$1.23M 0.03% 438
2021
Q1 		$5.78M Buy
16,592
+1,019
+7% +$337K 0.03% 473
2020
Q4 		$4.02M Buy
15,573
+5,033
+48% +$1.39M 0.02% 536
2020
Q3 		$3.02M Buy
10,540
+657
+7% +$154K 0.02% 540
2020
Q2 		$1.86M Buy
9,883
+1,549
+19% +$252K 0.02% 598
2020
Q1 		$1.03M Buy
+8,334
New +$1.3M 0.01% 611

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Storebrand Asset Management's ONC Position: Q2 2026 in Review

Storebrand Asset Management reduced its BeOne Medicines Ltd (ONC) stake by 20% in Q2 2026, selling an estimated $274K and leaving 3,738 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #649.

Storebrand Asset Management first reported a position in ONC in Q1 2020 and has held it in 26 quarters since. The position peaked at $7.3M in Q3 2021. 273 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Storebrand Asset Management held 3,738 shares of BeOne Medicines Ltd worth $1.07M as of Q2 2026.
  • Storebrand Asset Management sold 930 BeOne Medicines Ltd shares in Q2 2026, an estimated $274K.
  • BeOne Medicines Ltd made up ﹤0.01% of Storebrand Asset Management's portfolio in Q2 2026, its #649 holding.
  • Storebrand Asset Management first reported a position in BeOne Medicines Ltd in Q1 2020 and has held it in 26 quarters since.
  • Storebrand Asset Management's BeOne Medicines Ltd position peaked at $7.3M in Q3 2021.
  • 273 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.